At Roswell Park, we compare our survival data with data collected nationally by the Surveillance, Epidemiology and End Results (SEER) program.
Acute Myeloid Leukemia (AML)
In the United States as a whole, 26% of acute myeloid leukemia patients are still alive five years after diagnosis. However, the survival rate is higher for patients under 60 and for people with specific types of AML.
The graph below compares survival rates of patients treated at Roswell Park with SEER data of the survival rates for patients across the nation.
Chronic Myeloid Leukemia (CML)
In the United States as a whole, 67.6% of chronic myeloid leukemia patients are still alive five years after diagnosis.
Search clinical trials for leukemia.